Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 16.5% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 11.49% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
UNIFI
UFI
$142M
| $765K | ﹤0.01% |
54,435
+9,817
| +22% | +$148K |
|
1527
AppFolio
APPF
$7.97B
| $761K | ﹤0.01% |
8,394
-189
| -2% | -$19.1K |
|
1528
McGrath RentCorp
MGRC
$2.85B
| $758K | ﹤0.01% |
9,975
-1,709
| -15% | -$139K |
|
1529
Thryv Holdings
THRY
$87.5M
| $756K | ﹤0.01% |
33,755
+10,327
| +44% | +$265K |
|
|
HONE
1530
DELISTED
HarborOne Bancorp
HONE
| $755K | ﹤0.01% |
54,775
-11,067
| -17% | -$153K |
|
1531
Medifast
MED
$134M
| $755K | ﹤0.01% |
4,184
-3,952
| -49% | -$707K |
|
1532
Intercorp Financial Services
IFS
$6.07B
| $753K | ﹤0.01% |
32,176
| – | – |
|
1533
Upland Software
UPLD
$14M
| $748K | ﹤0.01% |
5,155
-956
| -16% | -$140K |
|
1534
Steven Madden
SHOO
$3.36B
| $744K | ﹤0.01% |
23,110
-7,237
| -24% | -$274K |
|
1535
IES Holdings
IESC
$12.9B
| $742K | ﹤0.01% |
49,206
+9,362
| +23% | +$151K |
|
1536
iShares MSCI India ETF
INDA
$6.59B
| $741K | ﹤0.01% |
18,833
+1,082
| +6% | +$45.6K |
|
1537
Century Casinos
CNTY
$35.7M
| $738K | ﹤0.01% |
102,504
+58,737
| +134% | +$549K |
|
1538
Cousins Properties
CUZ
$4.94B
| $738K | ﹤0.01% |
25,530
+1,146
| +5% | +$39.6K |
|
|
IVC
1539
DELISTED
Invacare Corporation
IVC
| $735K | ﹤0.01% |
573,903
+173,592
| +43% | +$229K |
|
1540
Kite Realty
KRG
$5.26B
| $732K | ﹤0.01% |
42,341
-88,584
| -68% | -$1.83M |
|
1541
Kratos Defense & Security Solutions
KTOS
$9.96B
| $731K | ﹤0.01% |
52,701
+5,641
| +12% | +$87.7K |
|
|
GTLS
1542
DELISTED
Chart Industries
GTLS
| $725K | ﹤0.01% |
4,334
-43
| -1% | -$7.34K |
|
|
TUP
1543
DELISTED
Tupperware Brands Corporation
TUP
| $723K | ﹤0.01% |
+114,021
| New | +$1.27M |
|
|
BNFT
1544
DELISTED
Benefitfocus, Inc.
BNFT
| $722K | ﹤0.01% |
92,863
-87,915
| -49% | -$868K |
|
1545
CytomX Therapeutics
CTMX
$717M
| $717K | ﹤0.01% |
+391,860
| New | +$750K |
|
|
FBC
1546
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $717K | ﹤0.01% |
20,233
-4,406
| -18% | -$163K |
|
1547
Cato Corp
CATO
$55.7M
| $715K | ﹤0.01% |
61,581
-27,231
| -31% | -$358K |
|
1548
Urban Edge Properties
UE
$2.73B
| $714K | ﹤0.01% |
47,428
-569,932
| -92% | -$10.2M |
|
|
AXIA
1549
DELISTED
AXIA Energia
AXIA
| $713K | ﹤0.01% |
101,506
-2,490
| -2% | -$16.8K |
|
1550
MP Materials
MP
$10.2B
| $713K | ﹤0.01% |
22,212
+5,357
| +32% | +$216K |
|
Similar funds
Cliff Asness's Q2 2022 Portfolio in Review
As of Q2 2022, Cliff Asness held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Cliff Asness's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Cliff Asness's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- Cliff Asness added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- Cliff Asness's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- Cliff Asness fully exited Roku in Q2 2022, selling an estimated $32.5M.
- Cliff Asness's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- Cliff Asness opened 150 new positions and closed 187 in Q2 2022.
- Cliff Asness's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.